Products Details

  • Shop
  • Brand Details

Typbar TCV Vaccination

Availability: In Stock Category: Typhoid

Typbar TCV – Bharat Biotech

Indication and Usage –

  • Typbar-TCV can be administered to infants of age ≥6 months to ≤45 years, children and adults as a single dose.
  • This is T-cell dependent which induces Vi antibodies that neutralize Vi antigen unlike T-cell independent plain Vi polysaccharide vaccines.
  • The vaccine full fills WHO requirements for Typhoid Vi Conjugate vaccine.


Dosage and Administration –

  • Typbar-TCV™ should be given intra muscularly in the deltoid or the vastus lateralis of subjects.
  • The immunizing dose for adults, children and infants of age ≥6 months to ≤45 years is single dose of 0.5 mL; a booster dose may be given after 3 years.


Contraindications –

  • Hypersensitivity to any constituent of the vaccine.
  • Pregnant & lactating women.
  • In the event of fever or severe infection.


 Adverse reactions –

  • The most common general and local adverse events were fever (5-10%) and pain at injection site (2-3%) post vaccination. All these events were resolved within 48 hours with symptomatic treatment.
  • Uncommon adverse events observed were itching, swelling, malaise and myalgia.


Drug interactions and other interactions –

  • For concomitant or co-administration use different injection sites and separate syringes.
  • Typbar-TCV should not be mixed with any other vaccine or medicinal product, because the interactions with other vaccines or medical products have not been established.
  • Safety and effectiveness have not been established in pregnant women and in nursing mothers.

Add a Review

Your email address will not be published. Required fields are marked *